Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers von Mzayek, Fawaz, Deng, Haiyan, Mather, Frances J, Wasilevich, Elizabeth C, Liu, Huayin, Hadi, Christiane M, Chansolme, David H, Murphy, Holly A, Melek, Bekir H, Tenaglia, Alan N, Mushatt, David M, Dreisbach, Albert W, Lertora, Juan J L, Krogstad, Donald J

Volltext

Evaluation of a Continuous Decontamination Technology in an Intensive Care Unit von BSN, Tami Inman, Chansolme, David

Volltext

Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare Costs von Schmitt, Steven, McQuillen, Daniel P., Nahass, Ronald, Martinelli, Lawrence, Rubin, Michael, Schwebke, Kay, Petrak, Russell, Ritter, J. Trees, Chansolme, David, Slama, Thomas, Drozd, Edward M., Braithwaite, Shamonda F., Johnsrud, Michael, Hammelman, Eric

Volltext

The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections von Redell, Mark, Sierra-Hoffman, Miguel, Assi, Maha, Bochan, Markian, Chansolme, David, Gandhi, Anurag, Sheridan, Kathleen, Soosaipillai, Ivan, Walsh, Thomas, Massey, Jill

Volltext

443. The CHROME Study, a Real-World Experiential Registry of the Use of Oritavancin for Treatment of Gram-Positive Infections von Redell, Mark, Sierra-Hoffman, Miguel, Assi, Maha, Bochan, Markian, Chansolme, David, Gandhi, Anurag, Sheridan, Kathleen R, Soosaipillai, Ivan, Walsh, Thomas L, Massey, Jill

Volltext

Individual volunteer received daily oral doses of AQ-13 for 3 d (day 1, 700; day 2, 700; and day 3, 350 mg) von Mzayek, Fawaz, Haiyan Deng, Mather, Frances J, Wasilevich, Elizabeth C, Huayin Liu, Hadi, Christiane M, Chansolme, David H, Murphy, Holly A, Melek, Bekir H, Tenaglia, Alan N, Mushatt, David M, Dreisbach, Albert W, Lertora, Juan J. L, Krogstad, Donald J

Volltext bestellen

Changes in the QTc interval from baseline were determined using the Rozinn Electronics system software to evaluate the Holter recordings von Mzayek, Fawaz, Haiyan Deng, Mather, Frances J, Wasilevich, Elizabeth C, Huayin Liu, Hadi, Christiane M, Chansolme, David H, Murphy, Holly A, Melek, Bekir H, Tenaglia, Alan N, Mushatt, David M, Dreisbach, Albert W, Lertora, Juan J. L, Krogstad, Donald J

Volltext bestellen

Individual volunteers received daily oral doses of CQ for 3 d (day 1, 600; day 2, 600; and day 3, 300 mg) von Mzayek, Fawaz, Haiyan Deng, Mather, Frances J, Wasilevich, Elizabeth C, Huayin Liu, Hadi, Christiane M, Chansolme, David H, Murphy, Holly A, Melek, Bekir H, Tenaglia, Alan N, Mushatt, David M, Dreisbach, Albert W, Lertora, Juan J. L, Krogstad, Donald J

Volltext bestellen